Welcome to Blood Cancer United
The Leukemia & Lymphoma Society is now Blood Cancer United. Join us.
Blood Cancer United is an evolution—not a new beginning—that will help us meet our bold goal: to enable patients with blood cancer to gain more than one million years of life by 2040.
With the name Blood Cancer United, we can now reach more people who need us—people affected by all 100+ types of blood cancer.
Our mission is not changing. And we will continue to be a global leader in blood cancer—research, support, and advocacy.
Our bold goal
By 2040, Blood Cancer United will enable people with blood cancer to gain more than one million years of life.
This means more birthdays, more graduations, more cherished moments and memories with family and friends.

Our organizational strategy: Extending and improving lives
Since we began in 1949, we’ve made tremendous strides for the blood cancer community. Some blood cancers can now be cured, and others can be managed as long-term chronic conditions. So, we measure our progress not just by cures, but by all the people who can live longer, more active lives after a blood cancer diagnosis.
We do this by:
- Looking for the new ideas, funding the science, and bringing together the necessary elements, experts, and innovations to help accelerate progress
- Protecting access to high-quality, affordable health coverage and funding for vital research into new, better treatments
- Providing support to new and existing patients, survivors, caregivers, and healthcare professionals
- Developing and implementing novel programmatic and research efforts that focus on survivorship, caregiving, clinical trials, equitable access to care, and quality of life
We’re committed to transforming lives through a new three-year strategic plan to kickstart our efforts to meet this bold goal, spanning July 1, 2024, through June 30, 2027. This plan outlines five key focus areas:
- Accelerate cures and treatments: Guide research and improve outcomes
- Support everyone experiencing blood cancer: Advance access and foster quality care from diagnosis through survivorship
- Galvanize communities: Unite volunteers, philanthropists, and other supporters to champion and advocate for those with blood cancer
- Develop breakthrough capabilities: Foster a culture of continuous discovery to unlock new resources that will improve and extend lives
- Empower people: Cultivate belonging and build a sustainable organization where teams can thrive
By prioritizing these five areas, we have a clear roadmap for how we will achieve our bold goal.
Join us in reaching our bold goal!
Who we are
We are Blood Cancer United, and we believe everyone with blood cancer deserves a longer, better life.
That’s why we are on a mission to cure blood cancer and improve the quality of life of all patients and their families. How? We fund life-saving blood cancer research around the world, provide free information and support services for patients and their families, and are the voice for those seeking access to quality, affordable, coordinated care.
With your help, we have invested more than $1.8 billion in groundbreaking research supporting many of today's most innovative approaches to treatment—helping those with blood cancer not only survive but also thrive.










Maximizing our impact
Each day, our vibrant group of researchers, volunteers, philanthropists, advocates, healthcare professionals, and nonprofit leaders works to find treatments for blood cancers and to help every patient access the care they need. We’re dedicated to addressing gaps in cancer outcomes and healthcare that disproportionately impact minority and rural communities and other underserved populations.
Education and support
We are the leading source of free education and support for blood cancer patients and families. We provide personalized, one-on- one support, including helping patients find and enroll in clinical trials.
Policy and advocacy
With our nationwide grassroots network of more than 50,000 active online volunteers, we drive policy changes that accelerate the development of new cancer treatments and break down barriers to care.
Research
We are the largest nonprofit funder of blood cancer research, supporting over 100 scientists last year alone at the world's most prestigious institutions with Blood Cancer United Research Grants.
We've prioritized investments in research, patient services, and advocacy, so we can better address the challenges blood cancer patients face. We’re focusing on eight priorities that are bringing us closer to our goal of improving outcomes for all the diverse communities we serve.
Taking purposeful steps to make sure every patient has access to the highest-quality blood cancer care
Learn morePowering the scientific engine that drives blood cancer cures and brings hope to patients
Download PDFTransforming pediatric blood cancer treatment and creating a world where every child can survive cancer and thrive in survivorship
Download PDFAdvancing better treatments and ensuring that the widest range of blood cancer patients can participate in, and benefit from, clinical trials
Download PDFCreating programs that empower blood cancer survivors to successfully navigate blood cancer and live their best possible lives
Download PDFAdvocating for affordable healthcare for all blood cancer patients
Download PDFOffering resources so that no patient is denied treatment because they cannot afford it
Download PDFProviding patients, caregivers, and healthcare providers with the knowledge they need to aim for optimal outcomes and maximize quality of life
Download PDFImpact
We've prioritized investments in research, patient services, and advocacy, so we can better address the challenges blood cancer patients face.
Our history

Robert "Robbie" Roesler de Villiers, the son of a well-to-do New York family, was only sixteen when he passed away from leukemia in 1944. Five years later, frustrated by the lack of effective treatments for what was then considered a “hopeless disease,” his parents Rudolph and Antoinette de Villiers started a fundraising and education organization in their son's name.
Headquartered in a small Wall Street office, the Robert Roesler de Villiers Foundation had only a few volunteers and a tiny budget. The task was daunting: Most leukemia patients, especially children, died within three months of being diagnosed. Even by the mid-1950s, when first-generation chemotherapy drugs began to appear, the disease remained a stubborn challenge. The Foundation reported in its 1955 annual report: "As of this date, Leukemia is 100% fatal. This is almost a unique situation among the many diseases to which man is susceptible."
Driven by the de Villiers' belief that leukemia and other blood cancers were indeed curable, the Foundation grew steadily, opening its first chapters in the New York City area. The organization, after changing its name to The Leukemia Society, was renamed The Leukemia Society of America in the 1960s to communicate a broad, national reach. In 2000, it was renamed to The Leukemia & Lymphoma Society to reflect the expanding mission of the organization: to serve patients with all types of blood cancer. And now, in 2025, we are Blood Cancer United, representing all blood cancers and delivering crucial support, resources, research, and services to those who need them.
Financials
Read our 2024 annual report for more details on how we are working to meet our bold goal across all areas of our organization.
Partner with us
Blood Cancer United is dedicated to addressing gaps in cancer outcomes and healthcare that disproportionately impact minority and rural communities and other underserved populations
Supplier resources
Find the information and resources you’ll need as a valued supplier and team member. Let’s work together efficiently and cost-effectively using our procure-to-pay system
The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.